MARKET

CING

CING

Cingulate Inc
NASDAQ
3.930
-0.010
-0.25%
Opening 13:18 12/05 EST
OPEN
3.940
PREV CLOSE
3.940
HIGH
4.000
LOW
3.810
VOLUME
70.13K
TURNOVER
--
52 WEEK HIGH
6.01
52 WEEK LOW
3.200
MARKET CAP
26.56M
P/E (TTM)
-0.7348
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CING last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at CING last week (1117-1121)?
Weekly Report · 11/24 10:34
Cingulate Price Target Cut to $16.00/Share From $17.00 by Roth Capital
Dow Jones · 11/19 18:10
Cingulate Is Maintained at Buy by Roth Capital
Dow Jones · 11/19 18:10
Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $16
Benzinga · 11/19 18:00
Cingulate price target lowered to $16 from $17 at Roth Capital
TipRanks · 11/19 00:55
Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences
Reuters · 11/18 21:28
Weekly Report: what happened at CING last week (1110-1114)?
Weekly Report · 11/17 10:35
More
About CING
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.

Webull offers Cingulate Inc stock information, including NASDAQ: CING real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CING stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CING stock methods without spending real money on the virtual paper trading platform.